A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1992
11/26/1992	CA2102195A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting
11/25/1992	EP0515302A1 Treatment of fatigue syndrome with cholinesterase inhibitor
11/25/1992	EP0515301A2 Improvements in benzodiazepine treatment by cholinesterterase inhibitors
11/25/1992	EP0515144A1 1,3-Oxathiolanes useful in the treatment of hepatitis
11/25/1992	EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/25/1992	EP0514452A1 Use of insulin sensitizing agents to treat hypertension.
11/24/1992	US5166331 Antibiotics, viricides, antiinflammatory agents, wound healing agents, cytostatics, anesthetics, cholinergics or adrenergics
11/24/1992	US5166175 Treatment of ocular hypertension with a synergistic combination
11/24/1992	US5166142 Use of type ia antiarrhythmic agents to lower blood lipids
11/24/1992	US5165922 Treatment of breast cancer
11/19/1992	EP0514056A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry
11/19/1992	EP0514023A1 Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal
11/19/1992	EP0513917A1 Antiviral combinations containing nucleoside analogs
11/19/1992	EP0513878A2 Pharmaceutical compositions containing cationic surfactants
11/19/1992	EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
11/19/1992	EP0513778A2 Hybrid monoclonal antibodies and compositions containing them
11/19/1992	EP0389583B1 Preparation and use of a physiologically active polypeptide for treating aids
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/17/1992	US5164395 Treatment of herpes, ribonucleotide reductase inhibitor
11/17/1992	US5164377 Sulphated glycosaminoglycuronan with antithrombotic activity
11/17/1992	US5164189 Single layer transdermal drug administration system
11/17/1992	US5164188 Biodegradable ocular implants
11/12/1992	WO1992019765A1 Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019651A1 Luteinizing hormone releasing hormone antagonist peptides
11/12/1992	WO1992019270A1 Novel combination of medicaments
11/12/1992	WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	WO1992019266A1 Recombinant virus expressing carcinoembryonic antigen and methods of use thereof
11/12/1992	WO1992019262A1 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/12/1992	WO1992019244A2 A method for treating infectious respiratory diseases
11/12/1992	WO1992019239A1 Treatment of aberrant cellular states with biomodulators
11/12/1992	WO1992019182A2 Method of attenuation of neointimal proliferation
11/12/1992	WO1992016181A3 Composition for promoting tissue repair and regeneration
11/12/1992	CA2109528A1 A method for treating infectious respiratory diseases
11/12/1992	CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/11/1992	EP0512824A1 Anti-bacterial compound
11/11/1992	EP0299975B1 Composition for arresting angiogenesis and capillary, cell or membrane leakage
11/10/1992	US5162430 To a synthetic hydrophilic polymer, polyoxyethylene glycol; wound healing, slow release drug delivery
11/05/1992	DE4114330A1 Neue arzneimittelkombination New drug combination
11/04/1992	WO1992019232A1 Partial liquid breathing of fluorocarbons
11/04/1992	CA2067839A1 Use of estrogens or antiandrogens or estrogens in combination with antiandrogens for reversal of male sexual phenotype in poultry
10/1992
10/29/1992	WO1992018544A1 Sulfate polysaccharides, preparation method, pharmaceutical composition and utilization
10/29/1992	WO1992018132A1 Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
10/29/1992	WO1992018124A1 OPHTHALMIC COMPOSITIONS COMPRISING COMBINATIONS OF A CARBONIC ANHYDRASE INHIBITOR AND A β-ADRENERGIC ANTAGONIST
10/29/1992	WO1992018089A2 Use of steroidal and non-steroidal amines to sensitize multidrug-resistant cells
10/29/1992	DE4213005A1 Antikonzeption bei weiblichen primaten ohne beeinflussung des menstruellen zyklus Contraception in female primates without influencing the menstrual cycle
10/29/1992	CA2108363A1 Sulphated polysaccharides, process for their preparation, pharmaceutical composition and utilization
10/28/1992	EP0511075A1 Sulfated polysaccharides, process for their preparation, pharmaceutical composition and use thereof
10/28/1992	EP0510687A2 Infusion preparation
10/28/1992	EP0510186A1 Therapeutic uses of melanin
10/28/1992	EP0510052A1 Medicament for treatment of heart failure
10/28/1992	EP0345304B1 Pharmaceutical compositions
10/27/1992	CA2066834A1 Use of glycine/nmda receptor ligands for the treatment of drug dependence and withdrawal
10/27/1992	CA1309558C D-gl conjugate therapy
10/27/1992	CA1309557C Leukotriene antagonists
10/27/1992	CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/21/1992	EP0509906A1 Complexes of Polyadenylic acid with polyuridylic acid for the treatment of AIDS
10/21/1992	EP0509752A2 Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a beta-adrenergic antagonist
10/20/1992	US5157039 2-quinolinyl methoxy compounds, medical uses and intermediates therefor
10/16/1992	WO1992018127A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
10/16/1992	CA2108480A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
10/15/1992	WO1992017206A1 Wound healing
10/15/1992	WO1992017186A1 Compounds that prevent endotoxin shock and method of using the compounds
10/15/1992	WO1992017169A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function
10/14/1992	EP0507850A1 Determining the diuretic potency of candidate drugs
10/14/1992	EP0368933B1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes
10/13/1992	US5155218 Dna encoding human 5-ht1d receptors
10/13/1992	US5155128 Medicaments for the treatment of cerebral apoplexy
10/13/1992	US5155125 Orally Administering; having an aldose reductase inhibitory activity
10/13/1992	US5154854 Process for the preparation of stable dispersions of at least one water-immiscible liquid phase in an aqueous phase
10/13/1992	CA1308711C Derivatives of monophosphoryl lipid a and process for preparation
10/13/1992	CA1308660C Pharmaceutical compositions containing 1,3-dioxane alkenoic acid derivatives
10/07/1992	EP0507604A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
10/07/1992	EP0507256A2 Tyrosine phosphorylation in protozoa
10/07/1992	EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
10/06/1992	US5153205 Method to reduce introacular pressure without causing miosis
10/05/1992	WO1992017161A1 Chewable antacid compositions
10/02/1992	CA2064550A1 Tyrosine phosphorylation in protozoans
10/01/1992	WO1992016484A1 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
10/01/1992	WO1992016233A1 Pharmaceutical combination for the treatment of prostatic cancer containing a 5 alpha reductase inhibitor and an antiandrogen
10/01/1992	WO1992016226A1 Il-1 inhibitors
10/01/1992	WO1992016213A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen
10/01/1992	WO1992016181A2 Composition for promoting tissue repair and regeneration
09/1992
09/30/1992	EP0506197A1 Topical preparation containing a suspension of solid lipid particles
09/30/1992	EP0505841A2 Analgesic composition containing beta-carotene
09/30/1992	EP0505640A1 Improved therapeutic method
09/30/1992	EP0505487A1 Growth arrest of proliferating cells by transglutaminase inhibitors
09/30/1992	EP0505357A1 Method for antibody targeting of diagnostic or therapeutic agents
09/30/1992	CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage
09/27/1992	WO1992017183A1 Sequential dosing of antifungal and antiinflammatory compositions
09/27/1992	CA2107237A1 Sequential dosing of antifungal and antiinflammatory compositions
09/26/1992	CA2061477A1 Analgesic composition containing beta-carotene
09/22/1992	WO1992016235A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof
09/22/1992	US5149782 Macromolecular drug linked to hydrophobic membrane blending agent for insertion; cleavably linked blocking agent
09/22/1992	US5149718 Biological fluid purification system
09/22/1992	US5149691 Applying to dental tissue; synergistic
09/22/1992	US5149527 Administering to induce production of macrophages specifically cytotoxic for tumor cells
09/22/1992	CA2105378A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof
09/22/1992	CA1307739C Anti-inflammatory compositions

1 ... 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 ... 1151